S
Sonia G. Andrade
Researcher at Oswaldo Cruz Foundation
Publications - 87
Citations - 4243
Sonia G. Andrade is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Trypanosoma cruzi & Chagas disease. The author has an hindex of 28, co-authored 86 publications receiving 3953 citations. Previous affiliations of Sonia G. Andrade include Federal University of Bahia.
Papers
More filters
Journal ArticleDOI
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.
Bianca Zingales,Sonia G. Andrade,Briones,David A. Campbell,Egler Chiari,Octavio Fernandes,Felipe Guhl,Eliane Lages-Silva,Andrea M. Macedo,Carlos Renato Machado,Michael A. Miles,A J Romanha,Nancy R. Sturm,Michel Tibayrenc,Alejandro G. Schijman +14 more
TL;DR: In an effort to unify the nomenclature of Trypanosoma cruzi, the causative agent of Chagas disease, an updated system was agreed upon at the Second Satellite Meeting that T. cruzi strains should be referred to by six discrete typing units.
Journal ArticleDOI
The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications.
Bianca Zingales,Michael A. Miles,David A. Campbell,Michel Tibayrenc,Andrea M. Macedo,Marta Maria Geraldes Teixeira,Alejandro G. Schijman,Martin S. Llewellyn,Eliane Lages-Silva,Carlos Renato Machado,Sonia G. Andrade,Nancy R. Sturm +11 more
TL;DR: It is concluded that greater advances in knowledge on pathogenic and epidemiological features of these parasites are expected in the coming decade through the comparative analysis of the genomes from isolates of various DTUs.
Journal ArticleDOI
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro J. Romanha,Solange L. de Castro,Maria de Nazaré Correia Soeiro,Joseli Lannes-Vieira,Isabela Ribeiro,André Talvani,Bernadette Bourdin,Bethania Blum,Bianca P. Olivieri,Carlos L. Zani,Carmenza Spadafora,Egler Chiari,Eric Chatelain,Gabriela Costa Chaves,José E. Calzada,Juan M. Bustamante,Lucio H. Freitas-Junior,Luz Romero,Maria Terezinha Bahia,Michel Lotrowska,Milena Botelho Pereira Soares,Sonia G. Andrade,Tanya Armstrong,Wim Degrave,Zilton A. Andrade +24 more
TL;DR: An in vitro and in vivo flowchart was designed to serve as a general and standardised protocol for screening potential drugs for the treatment of Chagas disease.
Journal ArticleDOI
Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology
TL;DR: The findings suggest that the biological behavior together with isoenzymes patterns and pathological pictures in the vertebrate host can be an important tool for establishing correlations between strains behavior and clinico-pathological manifestations of Chagas' disease in different geographical areas.
Journal Article
Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
TL;DR: A test was made of the susceptibility of 30 strains of Trypanosoma cruzi to chemotherapy with nifurtimox and benznidazole, finding that type I strains displayed high susceptibility, type II strains showed medium to high susceptible, and type III strains were highly resistant to both drugs.